Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823433 · ClinicalTrials.gov registry record · Early Phase 1
Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood
A Early Phase 1 study, sponsored by Corewell Health East.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT00823433 is a Early Phase 1 study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 25 participants.
The verdict
NCT00823433, a Early Phase 1 study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
Pregnant,laboring women will receive 2 grams of oral penicillin V before delivery. At the time of delivery of the infant, umbilical vein cord blood will be obtained from the umbilical cord. These cord blood samples will be sent for bioassay of penicillin levels.
Interventions
- DRUG oral penicillin V
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00823433
The ClinicalTrials.gov registry entry for NCT00823433 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oral penicillin V is the first listed.
NCT00823433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00823433 about?
NCT00823433 is a clinical study titled "Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood". Pregnant,laboring women will receive 2 grams of oral penicillin V before delivery. At the time of delivery of the infant, umbilical vein cord blood will be obtained from the umbilical cord. These cord blood samples will be sent for bioassay of penicillin levels.
What is the current status of trial NCT00823433?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2009-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00823433?
The interventions under investigation include: oral penicillin V (DRUG).
Who is sponsoring clinical trial NCT00823433?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.